Trump Takes On the Fed, US-Intel Deal, Why Bankruptcies Are Up, OpenAI's Longevity Breakthrough

All-In with Chamath, Jason, Sacks & Friedberg Podcast Recap

Published:

What Happened

In an unprecedented move, President Trump fired Fed Governor Lisa Cook, sparking a legal battle over the authority to remove Fed governors, who can traditionally only be dismissed for cause. Lisa Cook faces allegations of mortgage fraud and maintaining two primary residences, leading her to sue the president. The emergency hearing around her dismissal could escalate to the Supreme Court, with Polymarket predicting a 25% probability of her ousting by year's end.

Chamath Palihapitiya criticized the Federal Reserve's perceived partisan nature, questioning its effectiveness in modern monetary policy. He suggested that integrating real-time blockchain data could enhance economic metrics, while David Friedberg stressed the importance of maintaining the Fed's independence and the significance of the 14-year term for its governors. David Sacks accused Fed Chair Jerome Powell of politically motivated delays in interest rate hikes, contributing to asset bubbles.

The US government's 10% stake acquisition in Intel under the CHIPS Act highlights a strategic shift akin to China's approach in supporting critical industries. Chamath Palihapitiya and David Sacks argued for equity stakes in companies receiving taxpayer funds, advocating for a sovereign wealth fund to manage these assets. This contrasts with the US's historical role as a lender without equity benefits, as seen in the 2008 TARP program.

Corporate bankruptcies have surged to the highest levels since 2010, with 446 large cases recorded by July 2025. This spike is attributed to the end of artificially suppressed interest rates and a lack of creative market destruction. Retail giants like Forever 21 face challenges due to high leverage and shifting consumer behaviors, while commercial real estate grapples with impending debt refinancing hurdles.

OpenAI's development of the GPT-4B micro model has significantly advanced cellular rejuvenation by enhancing Yamanaka factors' effectiveness by 50 times. While this breakthrough offers promising avenues for reversing aging, the risk of unwanted outcomes, such as cells acting cancerous, remains a concern. Human clinical trials and therapeutics are in the pipeline, with drug approval anticipated in 7 to 12 years.

Political decisions regarding vaccines also garnered attention, with RFK withdrawing federal mRNA vaccine funding and altering CDC recommendations for COVID vaccines. The societal resistance to questioning vaccine protocols highlights a broader skepticism towards government agencies like the CDC, perceived as politically influenced rather than impartial.

Key Insights

View all All-In with Chamath, Jason, Sacks & Friedberg recaps